Add BrightSurf on Google Email

Genetic risk for atypical heart attack in women identified

A new study has found a genetic factor on chromosome 6 that increases the risk of spontaneous coronary artery dissection (SCAD), a rare and atypical form of heart attack primarily affecting young to middle-aged women. The genetic variant, known as rs9349379, is also associated with a small protective effect from classic heart attacks.

SourceUniversity of Leicester·JournalJournal of the American College of Cardiology·DateJan 14, 2019

Higher risk of heart attack on Christmas Eve

A Swedish study found that the risk of heart attack peaks at around 10 pm on Christmas Eve, especially for older and sicker individuals due to heightened emotional stress. This risk is also higher during New Year's and Midsummer holidays, as well as Monday mornings.

SourceBMJ Group·JournalThe BMJ·DateDec 12, 2018

Statins overprescribed for primary prevention

A comprehensive statistical modeling study found that statins are recommended far too often, with the benefits outweighing the harms only in people with a high risk of cardiovascular disease. The researchers recommend discussing individual risk and side effects with doctors before taking statins as a preventive measure.

SourceUniversity of Zurich·JournalAnnals of Internal Medicine·DateDec 6, 2018

Among heart attack survivors, drug reduces chances of second heart attack or stroke

A large international clinical trial found that alirocumab, a PCSK9 antibody, reduced the chance of additional heart problems or stroke in heart attack survivors. LDL cholesterol levels decreased by 50% with alirocumab treatment, leading to a 15% reduction in risk of death from coronary heart disease, another heart attack, or stroke.

SourceUniversity of Colorado Anschutz Medical Campus·JournalNew England Journal of Medicine·DateNov 7, 2018

Antibodies linked to heart attacks

Researchers at Karolinska Institutet discovered high levels of antiphospholipid antibodies in patients who suffered a heart attack without any autoimmune conditions. The study involved 800 patients and found that 11% had elevated IgG antibody levels, which is associated with blood clots.

SourceKarolinska Institutet·JournalAnnals of Internal Medicine·DateOct 22, 2018

Wearable defibrillator lowers sudden cardiac death, but only when you wear it

A UCSF-led study found that wearable cardioverter defibrillators lower mortality among patients who wear them consistently, but do not significantly reduce sudden cardiac death. The devices were more effective in reducing overall mortality, with a 35.5% lower risk of death compared to those who did not wear the device.

SourceUniversity of California - San Francisco·JournalNew England Journal of Medicine·DateSep 26, 2018